Because pharmacological inhibition of Sglt2-mediated glucose reabsorption effectively reduces blood glucose levels in patients with type 2 diabetes (38), the reduction of Sglt2 protein level at the brush border membrane offers the explanation for the glycosuria observed in these mice (Fig. 5). The gene discussed is SLC5A2; the disease is type 2 diabetes mellitus.